Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: When President Pierre Nkurunziza hands over power, it could be the first truly peaceful transfer of authority in the East African nation since independence in 1962. But the coronavirus poses a threat to the May 20 vote. Burundi has kicked out World Health Organization workers after concerns were raised. The WHO Africa director messaged the Africa Centers for Disease Control and Prevention chief about political rallies the day that Burundi’s campaigning launched and images of crowds circulated online. Authorities have been accused by critics of downplaying the pandemic and citing divine protection. But the government appears to be using virus measures to limit election observers, warning the East African regional bloc on May 8 that arriving foreigners face a 14-day quarantine. More than the virus, however, it’s the fear of violence that weighs on many of the more than 5 million people eligible to vote. Government agents have been accused of harassing the main opposition party, the CNL, whose leader Agathon Rwasa is believed to be in a close race with Nkurunziza’s chosen successor in the ruling CNDD-FDD, Evariste Ndayishimiye. More than 145 CNL members have been arrested since campaigning began on April 27, according to SOS Medias Burundi, a group of independent journalists. Police spokesman Pierre Nkurikiye has accused Rwasa of making “incendiary and defamatory” remarks and inciting revolt. Rwasa, the deputy parliament speaker, has drawn large crowds despite the risks of openly supporting him, according to an online group of activists known as i-Burundi. The group worries that a rigged election could spark the kind of street demonstrations that marked the previous vote in 2015. “The ruling party was hoping to use this post-Nkurunziza election to gain a semblance of legitimacy, but given what’s happening we might end up with more violence,” i-Burundi said in an interview. “People want change. ... But the ruling party has the incumbent advantage and controls the electoral process.” Rwasa told The Associated Press he feels it’s important not to boycott the election even if the outcome is not expected to be fair. “Everything has its right time,” he said. “Right now, it is not the time to give up and abandon our people.” Ndayishimiye, a retired general, would be a weak president because he will be a front for Nkurunziza and other powerful ruling party members, said David Gakunzi, a Burundian political analyst: “He consults but he will fear to take independent decisions.” Ndayishimiye fought alongside Nkurunziza as a rebel in the civil war from 1993 to 2005 that killed about 300,000 people. Nkurunziza was chosen by lawmakers to be president during the peace process known as the Arusha Accords, which specified that a president’s term can be renewed only once. But Nkurunziza, who won a second term in 2010, said he was eligible for a third term in 2015 because he had not been chosen the first time by universal suffrage. The deadly turmoil that followed badly damaged ties with the international community, and Burundi became the first country to leave the International Criminal Court after it started investigating allegations of abuses. The U.N. human rights office reported more than 300 extrajudicial killings and was kicked out of the country. Nkurunziza survived a coup attempt shortly after the 2015 vote while traveling in Tanzania and has left Burundi only once since then. Meanwhile international donors have cut support, leaving the government struggling. It has ordered citizens to pay for the upcoming vote. Many Burundians were surprised when the president announced in 2018 that he was serving his last term. Skepticism persists. The government has approved legislation that bestows upon Nkurunziza the title of “paramount leader” after he steps down. “It’s hard to know what’s going to happen ... Nkurunziza has a track record of being quite unpredictable,” said researcher Lane Hartill of the Burundi Human Rights Initiative. “Both the ruling party and the main opposition party, the CNL, are convinced their candidates are going to win the presidential election. It’s telling, though, that government officials continue to arrest large numbers of CNL members.” Even some senior members of the ruling party are tired of rights violations and the cratering economy but are afraid to speak out for fear of losing their jobs or being killed, Hartill said. Burundi’s government has denied allegations it targets its people, calling them malicious propaganda by dissidents. Memories of the 2015 violence are still raw. Jean Baptiste Bakunzi said he remains traumatized by his brother’s death at the hands of the police and the Imbonerakure, a militarized youth group associated with the ruling party. His brother, accused of participating in anti-government activities, “knelt down and begged them to save his life,” Bakunzi said. “Instead, one policeman pulled the trigger and shot him dead,” he said. “Whoever opposes the ruling party becomes an enemy even today.” The violence has dimmed hopes for those outside Burundi who will not be able to vote. Over 330,000 refugees are sheltering in Tanzania, Uganda, Rwanda and Congo, according to U.N. figures. “These elections will not bring hope for us because we have lost so much,” said Solange Teta, a refugee in Rwanda. “The ruling party candidate cannot alleviate our suffering.” Sporadic violence persists. Police said two people were killed and eight wounded in a grenade attack Sunday on a bar in Bujumbura that’s a popular hangout for ruling party supporters. Opposition supporters worry the security services may retaliate. Charles Nditije, a former government minister who lives in exile, described the election as a “joke,” calling the polls a formality aimed at installing Nkurunziza’s chosen successor. “What Burundians want now is anything that can bring to (an) end the reign of CNDD-FDD. But the ruling (party) candidate will fight tooth and nail to win fraudulently and set another round of crisis,” he said. Hartill, the Burundi researcher, said disputed election results could put the country back on edge. The big question, he said, is whether the opposition leader will “say enough is enough.” ___ Ssuuna reported from Kigali, Rwanda. Eloge Willy Kaneza in Nairobi, Kenya, contributed. Claim: Burundi defies COVID-19 for election ending a bloody rule.
[A]: Burundi is pushing ahead with an election on Wednesday that will end the president’s divisive and bloody 15-year rule.


[Q]: Paragraph: The Supreme Judicial Court said MIT cannot be blamed for the death of 25-year-old Han Nguyen, who jumped from the top of a campus building minutes after a professor confronted him about an offensive email. But it found that schools can be liable if they fail to act after they become aware that a student has attempted suicide while enrolled, or shortly before entering, or learn that the student had threatened to commit suicide. Gary Pavela, a consultant on law and policy issues in higher education, said he’s unaware of another state appellate court that has explicitly found that universities have a duty to prevent suicide in limited cases and defines those circumstances. “This will be very newsworthy to colleges around the country,” said Pavela, who has written a book about the legal questions surrounding student suicides. Jeffrey Beeler, an attorney for Nguyen’s estate, said they were disappointed the court sided with MIT, but believe its ruling will nonetheless “save student lives going forward.” An MIT spokeswoman said in a statement that Nguyen’s death was a tragedy and students’ well-being is of “paramount importance to the school.” Spokeswoman Kimberly Allen said the school already offers a “robust network” of services for students and “continually considers ways to enhance those resources.” The court noted that Nguyen never told anyone at MIT that he planned to kill himself or tried to kill himself while enrolled at the school. Furthermore, he was living off campus instead of a dormitory under “daily observation,” the court said. But the judges said schools must take “reasonable measures” to help students they know have attempted suicide while at the school or have threatened to kill themselves. That would include initiating a suicide prevention protocol, getting the student in the care of a medical professional, or contacting police, fire or emergency medical personnel. “It requires the school to really have a lot of information that the suicide is likely and the reasonable measures that the school needs to take are not extremely onerous,” said Naomi Shatz, an attorney who’s not involved in the case. A group of 18 colleges and universities — including Harvard University and Boston College — told the court that holding MIT responsible for Nguyen’s death would have far-reaching consequences by causing officials with no medical expertise to overreact to concerns out of fear of liability. Nguyen’s professors shared concerns about his mental health in the months leading up to his death, and one encouraged his colleagues to pass him or they might have “blood on their hands.” In a telephone call 11 minutes before he killed himself, a professor “read him the riot act” over an email Nguyen sent to another MIT official that they believed was inappropriate, court records said. The family said that the school should have known that “mishandling this fragile student” would result in his suicide. But MIT said the school wasn’t aware of the severity of his condition, noting that he was treated by outside professionals and refused on-campus resources. None of the professionals who treated Nguyen while he was at MIT believed he was an imminent risk of killing himself, the school said. ___ Follow Alanna Durkin Richer at http://twitter.com/aedurkinricher . Read more of her work at http://bit.ly/2hIhzDb . Claim: Court says schools can be liable for suicides but clears MIT.
[A]: Schools can be held liable for student suicides in certain circumstances, Massachusetts’ highest court said Monday in a ruling that also cleared the Massachusetts Institute of Technology of responsibility for the death of a graduate student who killed himself on campus in 2009.


[Q]: Paragraph: We won’t require a discussion of costs in this story because the use of zoledronic acid for early stage breast cancer is still up in the air. However, since the drug is already being sold for other indications, the story would have been better if it had told readers something about the costs of using the drug for approved indications. The article accurately framed the only potential benefit documented by the AZURE study: that it might provide a recurrence and survival advantage among a subgroup of post-menopausal women… and that this results is something to be studied further. The article accurately reported on the incidence of a serious side effect among the women taking zoledronic acid. The article accurately characterized the main conclusions of the study and the results of a secondary subgroup analysis. It also told readers that an earlier trial reached a different conclusion and that other studies are underway, thus helping make clear that these results are just part of a larger picture. The story emphasized—through the quote of an independent expert—that the subgroup analysis indicating older women with early stage breast cancer might get some benefit should lead to further research rather than changing standard practice now. There was no hint of disease-mongering in this article. The article quoted an independent source. It also addressed conflicts-of-interest among the researchers. The story did point out that the women in this trial did receive standard therapy (and it did so more clearly than the other story we reviewed), though it did not specifically say what that treatment entails. We will give the story a satisfactory rating since it is not clear that there is a proven alternative that would provide the type of recurrence and survival benefits seen in a previous study of zoledronic acid for early stage breast cancer. The article did not make it clear that the FDA has not yet approved zoledronic acid as adjunctive treatment for women with early breast cancer. The article made it clear that zoledronic acid is already in use for other applications. The article did not appear to be overly reliant on a news release. Claim: Bone Drug Zometa Flops Overall as Breast Cancer Treatment
[A]:
This story offered a solid, informative overview of a randomized controlled trial called AZURE—which assessed the benefits and risks of zoledronic acid as a treatment for early stage breast cancer. Its clarity, and cautious interpretation of this clinical trial, make it stand out in comparison with the other story we reviewed on this topic. The story accurately described the main conclusions of the study and did not oversell the promise of a subgroup analysis showing that zoledronic acid might give post-menopausal women a survival advantage. The story pointed out specific adverse events, including bone disease in the jaws of some women in the trial.It pointed out financial support from the pharmaceutical company that sells the drug being studied. The article wasn’t perfect. It didn’t explain the regulatory status of zoledronic acid for women with early breast cancer. It expressed the survival advantage of the subgroup of post-menopausal women in relative rather than absolute terms. But then so did the study summary provided by the drug company which sponsored the trial. Journalists have limited access to study information at meeting presentations. And the author of the Healthday article was careful to point out that the results of AZURE should be regarded as preliminary. Zoledronic acid and other bone-density enhancing bisphosphonates have been employed as treatments for osteoporosis and to prevent skeletal complications among women with metastatic breast cancer. However, their role in the prevention of recurrence among women with early stage breast cancer isn’t clear. Animal studies suggest that bisphosphonates may have direct anti-tumor effects in bone. Proponents of zoledronic acid believe it may provide a significant advantage for women with early stage breast cancer—in terms of recurrence and survival. But the results of studies in humans have been contradictory. A large randomized controlled trial from Austria (the ABCSG-12 trial) published in 2009 suggested that the addition of three years of zoledronic acid to hormonal therapy following surgery for early stage breast cancer provided a 32% advantage in disease-free survival, compared to subjects who did not receive this drug. All the women in the ABCSG-12 trial had chemically induced menopause. The AZURE trial attempted to confirm the benefits of zoledronic acid in a different study population, one that included both premenopausal and postmenopausal women with early stage breast cancer. AZURE and other trials are important not only to assess any benefits of zoledronic acid but also to study its adverse effects—which include the potentially devastating side-effect of osteonecrosis of the jaw bone.